BackNutex Health Overview

Nutex Health Other Current Liabilities

Track Nutex Health's other current liabilities ($96M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$96.12M
274.12% YoYΔ $70.43M vs prior year quarter

Peer average

Loading

Nutex Health Other Current Liabilities History

Loading

Nutex Health vs. peers: Other Current Liabilities Comparison

Loading

Nutex Health Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Nutex Health (NUTX) FAQ

Nutex Health (NUTX) currently reports a other current liabilities of $96M as of March 2026. That compares with $26M in the prior-year period — up 274.1% year over year. Use the charts on this page to explore Nutex Health's other current liabilities history and peer comparisons.

Nutex Health's other current liabilities increased from $26M to $96M — a 274.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Nutex Health reported $96M in other current liabilities as of March 2026. That compares with $26M in the prior-year period — up 274.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $96M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Nutex Health, and consider following NUTX for alerts when major investors trade the stock.

Nutex Health is classified in the Consumer Staples sector. On other current liabilities, it currently shows $96M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Consumer Staples are usually more informative than comparing NUTX with unrelated industries.